Clarity Capital Partners LLC Grows Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG)

Clarity Capital Partners LLC lifted its holdings in ARK Genomic Revolution ETF (BATS:ARKGFree Report) by 12.5% in the 1st quarter, Holdings Channel.com reports. The firm owned 10,041 shares of the company’s stock after acquiring an additional 1,115 shares during the quarter. Clarity Capital Partners LLC’s holdings in ARK Genomic Revolution ETF were worth $289,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Hilltop Holdings Inc. increased its stake in ARK Genomic Revolution ETF by 6.0% during the 4th quarter. Hilltop Holdings Inc. now owns 7,652 shares of the company’s stock valued at $251,000 after purchasing an additional 433 shares in the last quarter. Park Avenue Securities LLC increased its stake in ARK Genomic Revolution ETF by 14.0% during the 1st quarter. Park Avenue Securities LLC now owns 11,667 shares of the company’s stock valued at $336,000 after purchasing an additional 1,435 shares in the last quarter. Principal Securities Inc. acquired a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $32,000. Goldman Sachs Group Inc. increased its stake in ARK Genomic Revolution ETF by 271.4% during the 4th quarter. Goldman Sachs Group Inc. now owns 642,800 shares of the company’s stock valued at $21,090,000 after purchasing an additional 469,740 shares in the last quarter. Finally, BKM Wealth Management LLC acquired a new position in ARK Genomic Revolution ETF during the 4th quarter valued at approximately $78,000.

ARK Genomic Revolution ETF Trading Down 0.5 %

ARK Genomic Revolution ETF stock traded down $0.11 during mid-day trading on Wednesday, reaching $23.46. 1,319,555 shares of the company traded hands. The company has a fifty day moving average price of $24.96 and a two-hundred day moving average price of $27.63.

About ARK Genomic Revolution ETF

(Free Report)

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.

See Also

Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKGFree Report).

Institutional Ownership by Quarter for ARK Genomic Revolution ETF (BATS:ARKG)

Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.